Selected article for: "activity investigation and acute ards respiratory distress syndrome"
Author: Nagarkatti, Prakash; Miranda, Kathryn; Nagarkatti, Mitzi
Title: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
  • Cord-id: fqxxhqyc
  • Document date: 2020_11_6
    • ID: fqxxhqyc
    Snippet: Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory disease caused by the severe acute respiratory syndrome coronavirus 2. A significant proportion of COVID-19 patients develop Acute Respiratory Distress Syndrome (ARDS) resulting from hyperactivation of the immune system and cytokine storm, which leads to respiratory and multi-organ failure, and death. Currently, there are no effective treatments against hyperimmune syndrome and ARDS. We propose that because immune cells expre
    Document: Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory disease caused by the severe acute respiratory syndrome coronavirus 2. A significant proportion of COVID-19 patients develop Acute Respiratory Distress Syndrome (ARDS) resulting from hyperactivation of the immune system and cytokine storm, which leads to respiratory and multi-organ failure, and death. Currently, there are no effective treatments against hyperimmune syndrome and ARDS. We propose that because immune cells express cannabinoid receptors and their agonists are known to exhibit potent anti-inflammatory activity, targeting cannabinoid receptors, and endocannabinoids deserve intense investigation as a novel approach to treat systemic inflammation, cytokine storm, and ARDS in patients with COVID-19.

    Search related documents:
    Co phrase search for related documents
    • active infection and acute lung injury: 1, 2, 3, 4, 5
    • active infection and adaptive innate: 1, 2, 3, 4, 5
    • active infection and adipose tissue: 1
    • active infection and low respiratory: 1, 2, 3, 4
    • active infection and low respiratory tract: 1
    • actively study and acute lung injury: 1
    • acute ards respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and adipose tissue: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and low respiratory tract: 1, 2
    • acute lung injury and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute lung injury and adipose tissue: 1, 2
    • acute lung injury and low respiratory: 1, 2, 3
    • acute lung injury and low respiratory tract: 1
    • adaptive innate and adipose tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12